International Journal of Hematology

Papers
(The H4-Index of International Journal of Hematology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma86
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib63
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells41
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature41
Post-transfusion purpura and adult primary thrombocytopenia32
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment30
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia27
Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors26
Advances in immune microenvironment profiling during multiple myeloma progression and therapy25
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST22
Carcinocythemia diagnosed on peripheral blood clot sections20
Managing massive gastrointestinal and abdominal haemorrhage in inherited bleeding disorders: experience from a pediatric cohort19
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma19
Acute megakaryoblastic leukemia with RBM15::MKL1 fusion presenting as neonatal acute liver failure: rescued by living-donor liver transplantation19
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets19
EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells18
Recent progress in T-cell malignancies including adult T-cell leukemia–lymphoma18
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study18
0.1155641078949